Skip to content
lifestyle.projectdiaspora.org
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
AlzeCure Pharma
AlzeCure Publishes its Interim Report for January – March 2026
May 6, 2026
Adjusted Timeline for the Previously Communicated Rights Issue
May 6, 2026
Last Patient has Completed AlzeCure’s Phase Ib Clinical Study with NeuroRestore ACD856
May 4, 2026
AlzeCure Pharma Publishes its Annual Report for 2025
May 3, 2026
AlzeCure Pharma to Present at Redeye Healthcare Day on April 14
May 3, 2026
AlzeCure Pharma to Present at Redeye Alzheimer’s Theme Event on April 9
May 2, 2026
AlzeCure Presents New Preclinical Data with NeuroRestore ACD856 at the Alzheimer’s Conference AD/PD
April 30, 2026
AlzeCure Pharma Carries Out a Fully Secured Rights Issue of Approximately SEK 30.1 million
April 30, 2026
AlzeCure Pharma to Present at Stora Aktiedagarna in Stockholm on March 11
April 28, 2026
AlzeCure Publishes its Year-End Report for January – December 2025
February 26, 2026
←
Previous Page
1
2
3
Next Page
→